B型流感病毒Yamagata系和Victoria系双重荧光PCR诊断方法的建立与应用

目的 建立一种新型的双重荧光PCR诊断方法,用于B型流感病毒By (B/Yamagata)和Bv(B/Victoria)亚系的准确分子分型.方法 从GenBank随机下载By和By HA(hemagglutinin)基因各50条序列,通过MEGA分析,利用Primer Primer软件设计亚系特异性引物和通用探针,建立双重荧光PCR诊断方法.用HAI(hemagglutination inhibition)实验确认的B型流感病毒亚系分离毒株和A型流感病毒进行特异性验证,用体外转录核酸拷贝数进行灵敏度实验.结果 2006-2010流感监测年份,对17 765份流感样病例咽拭标本中分离到B型流感病毒793株,本方法鉴定有152株By和641株Bv病毒,与HAI鉴定结果一致.本诊断方法的检测特异性达100％,灵敏度达102拷贝/μl,重复性变异系数＜3.5％.结论 本研究所建立的荧光PCR方法为流感实时监测提供了有力的技术支撑,适合于流感监测实验室对流感病毒的快速分子诊断.

Applicability of a sensitive duplex real-time PCR assay for identifying B/Yamagata and B/Victoria lineages of influenza virus

Objective To develop a novel sensitive duplex real-time PCR assay for accurately identifying B/Yamagata and B/Victoria lineages of influenza virus type B. Methods 50 HA （hemagglutinin） gene sequences coding for B/Yamagata and B/Victoria lineage, respectively, were randomly downloaded for GenBank and analyzed by software MEGA. Primers and probes specific for HA gene of B/Yamagata and B/Victoria lineages were designed by Primer Primer and then applied in the duplex real-time RT-PCR method that was followed developed. Influenza virus B type and A type isolated in our laboratory and typing-confirmed by HAI method were used as reference strains to determine the specificity of this assay and the sensitivity of the duplex amplification was evaluated by viral load testing in terms of in vitro transcribed RNA copy number. Results In 2006-2010, 793 influenza virus type B strains were isolated from 17 765 throat swab samples, among which 152 strains were differentiated as By lineage and 641 as By lineage by this assay. These results was agreement with that determined by HAI assay. This developed assay allows to accurately identify approximately 102 copies/μl for Bv and By lineage virus with intra-and inter- coefficient of variation （ CV ） 〈 3.5% and nearly 100% specificity. Conclusions This method provides sensitive and robust tool for routine diagnosis and on-time epidemiological examination of influenza virus, which could be applied in influenza surveillance laboratories for rapid molecular diagnosis.